• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型生殖技术中的卵巢过度刺激综合征:预防与治疗

Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.

作者信息

Navot D, Bergh P A, Laufer N

机构信息

Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Medical Center, New York, New York 10029.

出版信息

Fertil Steril. 1992 Aug;58(2):249-61. doi: 10.1016/s0015-0282(16)55188-7.

DOI:10.1016/s0015-0282(16)55188-7
PMID:1633889
Abstract

OBJECTIVE

To overview the world literature on ovarian hyperstimulation syndrome (OHSS) and modes of prevention and treatment of OHSS.

STUDY SELECTION

All the pertinent literature on OHSS, its prevention, and strategies for treatment were reviewed.

PREVENTION

Key to prevention is proper identification of the population at risk, which includes women with either the hormonal or the morphological signs of polycystic ovarian disease, high serum estradiol (E2) before human chorionic gonadotropin (hCG) administration (E2 greater than 4,000 pg/mL), multiple follicular response (greater than 35), younger age, and lean habitus. When a high risk situation is recognized, ovulatory dose of hCG may be reduced, avoided (with cycle cancellation), or substituted by gonadotropin-releasing hormone or its agonist. Luteal support with hCG is to be bypassed. To minimize risk of OHSS, endogenous pregnancy-drived hCG may be eluded by judicious cryopreservation of all embryos. Last, follicular aspiration will allow higher levels of E2 and larger number of follicles to be matured with lesser risk of OHSS than conventional ovulation induction without follicular aspiration.

TREATMENT

In-house for the severe and intensive care for the critical form. Meticulous fluid and electrolyte balance using both crystalloids and colloids (albumin) until hemoconcentration abates. Paracentesis is indicated for tight ascites, deteriorating kidney functions, and symptomatic relief. Diuretics may be prudently used once hemodilution is achieved. Dopamine drip may be used as a renal rescue, whereas heparin is indicated for thromboembolic phenomena and surgery reserved for abdominal catastrophies. Therapeutic interruption of an early gestation may be lifesaving when all other measures have failed.

CONCLUSIONS

Although severe and critical OHSS may not be completely avoided, early recognition of high-risk factors, judicious prevention schemes, and treatment strategies should reduce the complication and long-term sequelae of this iatrogenic syndrome.

摘要

目的

综述关于卵巢过度刺激综合征(OHSS)及其预防和治疗方式的世界文献。

研究选择

对所有关于OHSS、其预防及治疗策略的相关文献进行了综述。

预防

预防的关键在于正确识别高危人群,其中包括患有多囊卵巢疾病激素或形态学体征、人绒毛膜促性腺激素(hCG)给药前血清雌二醇(E2)水平高(E2大于4000 pg/mL)、多个卵泡反应(大于35个)、年龄较小以及体型消瘦的女性。当识别出高危情况时,可减少、避免使用排卵剂量的hCG(取消周期),或用促性腺激素释放激素或其激动剂替代。应避免使用hCG进行黄体支持。为将OHSS风险降至最低,可通过审慎冷冻保存所有胚胎来避免内源性妊娠驱动的hCG。最后,与不进行卵泡抽吸的传统排卵诱导相比,卵泡抽吸可使E2水平更高、更多卵泡成熟,且OHSS风险更低。

治疗

对重症和危重症患者进行重症监护。使用晶体液和胶体液(白蛋白)精心维持液体和电解质平衡,直至血液浓缩缓解。对于严重腹水、肾功能恶化及症状缓解,需进行腹腔穿刺引流。一旦实现血液稀释,可谨慎使用利尿剂。多巴胺滴注可作为肾脏保护措施,而肝素适用于血栓栓塞现象,手术则用于治疗腹部严重病变。当所有其他措施均失败时,早期妊娠的治疗性中断可能挽救生命。

结论

尽管严重和危重症OHSS可能无法完全避免,但早期识别高危因素、审慎的预防方案和治疗策略应能减少这种医源性综合征的并发症和长期后遗症。

相似文献

1
Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment.新型生殖技术中的卵巢过度刺激综合征:预防与治疗
Fertil Steril. 1992 Aug;58(2):249-61. doi: 10.1016/s0015-0282(16)55188-7.
2
Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU hCG.促性腺激素释放激素激动剂扳机后添加 1500IUhCG 导致严重的早发性卵巢过度刺激综合征。
Hum Reprod. 2013 Sep;28(9):2522-8. doi: 10.1093/humrep/det124. Epub 2013 Apr 30.
3
The prevention of ovarian hyperstimulation syndrome.卵巢过度刺激综合征的预防
J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5.
4
A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.对于有卵巢过度刺激综合征风险且正在接受控制性卵巢刺激的患者,采用促性腺激素释放激素激动剂触发排卵并积极进行黄体期支持。
Taiwan J Obstet Gynecol. 2015 Oct;54(5):583-7. doi: 10.1016/j.tjog.2015.08.012.
5
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol.在促性腺激素释放激素拮抗剂方案中使用注射用重组人促卵泡激素α或重组促卵泡素β治疗的患者中卵巢过度刺激综合征的预测
PLoS One. 2016 Mar 7;11(3):e0149615. doi: 10.1371/journal.pone.0149615. eCollection 2016.
6
GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.根据卵巢对刺激的反应进行 GnRHa 触发和个体化黄体期 hCG 支持:IVF 患者的两项前瞻性随机对照多中心研究。
Hum Reprod. 2013 Sep;28(9):2511-21. doi: 10.1093/humrep/det249. Epub 2013 Jun 9.
7
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.卵巢过度刺激综合征(OHSS)的流行病学与预防:综述
Hum Reprod Update. 2002 Nov-Dec;8(6):559-77. doi: 10.1093/humupd/8.6.559.
8
Symposium: Update on prediction and management of OHSS. Prevention of OHSS.研讨会:卵巢过度刺激综合征(OHSS)预测与管理的最新进展。OHSS的预防。
Reprod Biomed Online. 2009 Jul;19(1):33-42. doi: 10.1016/s1472-6483(10)60043-0.
9
A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.一种新的卵母细胞成熟触发方法,使用 1500IU 的人绒毛膜促性腺激素加 450IU 的卵泡刺激素,可能会降低所有体外受精刺激方案中的卵巢过度刺激综合征。
J Assist Reprod Genet. 2018 Feb;35(2):297-307. doi: 10.1007/s10815-017-1074-4. Epub 2017 Oct 30.
10
Successful pregnancies in patients with estrogenic anovulation after low-dose human chorionic gonadotropin therapy alone following hMG for controlled ovarian hyperstimulation.在使用人绝经期促性腺激素(hMG)进行控制性卵巢过度刺激后,仅接受低剂量人绒毛膜促性腺激素治疗的雌激素性无排卵患者成功妊娠。
J Assist Reprod Genet. 2005 Jan;22(1):37-40. doi: 10.1007/s10815-005-0819-7.

引用本文的文献

1
Impact of gonadotropin selection on risk of ovarian hyperstimulation syndrome in predicted high responders: a Menopur in Gonadotropin-releasing hormone Antagonist Single Embryo Transfer-High Responder trial analysis.促性腺激素选择对预测高反应者卵巢过度刺激综合征风险的影响:促性腺激素释放激素拮抗剂单胚胎移植-高反应者试验中Menopur的分析
F S Rep. 2025 Jul 19;6(3):251-260. doi: 10.1016/j.xfre.2025.07.003. eCollection 2025 Sep.
2
Risk prediction models for ovarian hyperstimulation syndrome: a systematic review and meta-analysis.卵巢过度刺激综合征的风险预测模型:一项系统评价与荟萃分析
BMC Pregnancy Childbirth. 2025 Aug 18;25(1):860. doi: 10.1186/s12884-025-07971-9.
3
Visualization analysis of ovarian hyperstimulation syndrome based on bibliometrics.
基于文献计量学的卵巢过度刺激综合征可视化分析
Medicine (Baltimore). 2025 May 16;104(20):e42342. doi: 10.1097/MD.0000000000042342.
4
Efficacy of Local N-Acetylcysteine Administration in Mitigating OHSS Parameters: A Comparative Analysis With Dopaminergic Agonist in the OHSS Model.局部给予N-乙酰半胱氨酸减轻卵巢过度刺激综合征参数的疗效:在卵巢过度刺激综合征模型中与多巴胺能激动剂的比较分析。
Int J Endocrinol. 2024 Dec 5;2024:1634072. doi: 10.1155/ije/1634072. eCollection 2024.
5
Severe ovarian hyperstimulation syndrome following sole gonadotropin-releasing hormone (GnRH) agonist trigger: a case series and literature review.单纯促性腺激素释放激素(GnRH)激动剂扳机后发生重度卵巢过度刺激综合征:病例系列及文献复习。
Arch Gynecol Obstet. 2024 Nov;310(5):2297-2304. doi: 10.1007/s00404-024-07740-7. Epub 2024 Sep 20.
6
Effect of aromatase inhibitors for preventing ovarian hyperstimulation syndrome in infertile patients undergoing in vitro fertilization: a systematic review and meta-analysis.芳香化酶抑制剂预防体外受精中不孕患者卵巢过度刺激综合征的效果:系统评价和荟萃分析。
Reprod Biol Endocrinol. 2024 Jul 23;22(1):85. doi: 10.1186/s12958-024-01258-y.
7
Pregnancy Outcomes of Assisted Reproductive Technology (ART) Cycle Complicated by Ovarian Hyperstimulation Syndrome (OHSS): Case Series Study.辅助生殖技术(ART)周期合并卵巢过度刺激综合征(OHSS)的妊娠结局:病例系列研究
Cureus. 2023 Jul 22;15(7):e42303. doi: 10.7759/cureus.42303. eCollection 2023 Jul.
8
Influencing of serum inflammatory factors on IVF/ICSI outcomes among PCOS patients with different BMI.血清炎症因子对不同 BMI 的多囊卵巢综合征患者 IVF/ICSI 结局的影响。
Front Endocrinol (Lausanne). 2023 Aug 24;14:1204623. doi: 10.3389/fendo.2023.1204623. eCollection 2023.
9
Biomarkers identification in follicular fluid of women with OHSS by using UPLC-MS method.采用 UPLC-MS 方法鉴定 OHSS 患者滤泡液中的生物标志物。
Front Endocrinol (Lausanne). 2023 Mar 8;14:1131771. doi: 10.3389/fendo.2023.1131771. eCollection 2023.
10
Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases.在不存在 FSHR 突变的情况下发生自发性和医源性卵巢过度刺激综合征:两例意外病例报告。
BMC Med Genomics. 2023 Mar 7;16(1):45. doi: 10.1186/s12920-023-01473-3.